Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4772-4777

  Martínez Pastor, Juan C ^a   Muñoz Mahamud, Ernesto ^a   Vilchez, Félix ^a   García Ramiro, Sebastián ^a   Bori, Guillem ^a   Sierra, Josep ^a   Martínez, José A ^a   Font, Lluis ^a   Mensa, Josep ^a   Soriano, Alex ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFOTAXIME; CEFTAZIDIME; CEFTIBUTEN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEBRIDEMENT; DEVICE REMOVAL; ENTEROBACTERIACEAE; FEMALE; FOLLOW UP; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; KNEE ARTHROPLASTY; KNEE PROSTHESIS; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTHESIS INFECTION; PROSTHETIC JOINT INFECTION; PSEUDOMONAS AERUGINOSA; REMISSION;

ACUTE DISEASE; AGED; C-REACTIVE PROTEIN; DEBRIDEMENT; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70350310342     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00188-09     Document Type: Article

References (17)

1. Aslam, S., B. W. Trautner, V. Ramanathan, and R. O. Darouiche. 2007. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob. Agents Chemother. 51:1556-1558.
2. Barberan, J., L. Aguilar, G. Carroquino, M. J. Giménez, B. Sánchez, D. Martínez, and J. Prieto. 2006. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients. Am. J. Med. 119:e7-e10.
3. Brouqui, P., M. C. Rousseau, A. Stein, M. Drancourt, and D. Raoult. 1995. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination. Antimicrob. Agents Chemother. 39:2423-2425.
4. Giulieri, S. G., P. Graber, P. E. Ochsner, and W. Zimmerli. 2004. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 32:222-228.
5. Hughes, J. G., E. A. Vetter, R. Patel, C. D. Schleck, S. Harmsen, L. T. Turgeant, and F. R. Cockerill III. 2001. Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. J. Clin. Microbiol. 39:4468-4471.
6. Labthavikul, P., P. J. Petersen, and P. A. Bradford. 2003. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob. Agents Chemother. 47:3967-3969.
7. Laffer, R. R., P. Graber, P. E. Ochsner, and W. Zimmerli. 2006. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin. Microbiol. Infect. 12:433-439.
8. Legout, L., E. Senneville, R. Stern, Y. Yazdanpanah, C. Savage, M. Roussel-Delvalez, B. Rosele, H. Migaud, and Y. Mouton. 2006. Treatment of bone and joint infections caused by gram-negative bacilli with a cefepime- fluoroquinolone combination. Clin. Microbiol. Infect. 12:1030-1033.
9. Moran, E., S. Masters, A. R. Berendt, P. McLardy-Smith, I. Byren, and B. L. Atkins. 2007. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J. Infect. 55:1-7. (Pubitemid 46888074)
10. Raad, I., H. Hanna, Y. Jiang, T. Dvorak, R. Reitzel, G. Chaiban, R. Sherertz, and R. Hachem. 2007. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob. Agents Chemother. 51:1656-1660.
11. Rimmele, T., E. Boselli, D. Breilh, S. Djabarouti, J. C. Bel, R. Guyot, M. C. Saux, and B. Allaouchiche. 2004. Diffusion of levofloxacin into bone and synovial tissues. J. Antimicrob. Chemother. 53:533-535.
12. Soriano, A., G. Bori, S. Garcia-Ramiro, J. C. Martinez-Pastor, T. Miana, C. Codina, F. Maculé, M. Basora, J. A. Martínez, J. Riba, S. Suso, and J. Mensa. 2008. Timing of antibiotic prophylaxis for primary total knee arthroplasty performed during ischemia. Clin. Infect. Dis. 46:1009-1014.
13. Soriano, A., S. Garcia, G. Bori, M. Almela, X. Gallart, F. Macule, J. Sierra, J. A. Martínez, S. Suso, and J. Mensa. 2006. Treatment of acute post-surgical infection of joint arthroplasty. Clin. Microbiol. Infect. 12:930-933.
14. Tanaka, G., M. Shigeta, H. Komatsuzawa, M. Sugai, H. Suginaka, and T. Usui. 1999. Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents: beta-lactams and fluoroquinolones. Chemotherapy 45:28-36. (Pubitemid 29027533)
15. Wenzel, R. P. 2004. The antibiotic pipeline-challenges, costs, and values. N. Engl. J. Med. 351:523-526.
16. Zimmerli, W., A. Trampuz, and P. E. Ochsner. 2004. Prosthetic-joint infections. N. Engl. J. Med. 351:1645-1654.
17. Zimmerli, W., A. F. Widmer, M. Blatter, R. Frei, and P. E. Ochsner. 1998. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 279:1537-1541. (Pubitemid 28233008)